Democrat Congressman Daniel Lipinski and Republican Congressman J. Randy Forbes have joined together in an increasingly partisan Washington D.C. to sponsor "The Patients First Act," H.R. 877. Their bill will prioritize stem cell research toward treating and curing patients. The Forbes/Lipinski bill promotes research and human clinical trials using stem cells that show the most potential of providing clinical benefit and are ethically obtained.
Congressman Forbes referred to a chart showing the difference in benefits from adult stem cells in human patients versus the so-called benefits in embryonic stem cells from peer-reviewed studies. There have been ZERO benefits from the politically-correct human embryonic stem cell destruction research. On the other hand, there have been cures and successful treatments of an astounding 73 diseases using adult stem cells.
Adult stem cells have benefited human patients with brain cancer, ovarian cancer, skin cancer, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Juvenile Myelomonocytic Leukemia, cancer of the lymph nodes, breast cancer, diabetes Type I (Juvenile), Crohn's Disease, rheumatoid arthritis, multiple sclerosis, chronic coronary artery disease, acute heart damage, Parkinson's Disease, spinal cord injury, stroke damage, sickle cell anemia, limb gangrene, jawbone replacement, skull bone repair, and many many more diseases.